News

Animal Health Investment Europe 2020

11. Januar 2020

Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2020)

Animal Health Investment Europe 2019

21. Januar 2019

Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2019)

VetBioNet grant

26. November 2018

VetBioNet grant - Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

Animal Health Investment Europe

25. Januar 2017

Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

CTI (new: Innosuisse) Project on APP

21. Dezember 2016

Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.

Parasite Glycobiology: A Bittersweet Symphony

12. November 2015

Parasite Glycobiology: A Bittersweet Symphony - Publication in PLOS Pathogens

Malcisbo at Glyco-Summer School in Braga, Portugal 23-25 September 2015

23. September 2015

Malcisbo at Glyco-Summer School in Braga, Portugal 23-25 September 2015 - Malcisbo has been invited to give a presentation on "Novel carbohydrate-based vaccines"

Ranked #47 in the Top 100 in Switzerland

16. September 2015

Ranked #47 in the Top100 in Switzerland - Malcisbo was ranked in the Top100 of Swiss Start-up companies.

Mycotoxin protects against nematodes

27. Mai 2014

Researchers at the ETH Zurich have isolated a protein from a fungus which combats nematodes.

Malcisbo participates in GlycoPar

01. Dezember 2013

Malcisbo is partner in GlycoPar, an EU FP7 funded training network.